Fargo, ND 的 過重 臨床試驗
8 項針對 過重 的研究正在 Fargo（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Lillestol Research LLC /ID# 281978, Fargo
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
招募中3 期
- Valley Weight Loss Clinic, Fargo
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Lillestol Research LLC, Fargo
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Lillestol Research, Fargo
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Fargo
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Lillestol Research, Fargo
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Lillestol Research LLC, Fargo
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Fargo
其他城市的 過重 試驗
- San Antonio, TX34 項研究
- Houston, TX33 項研究
- Chicago, IL28 項研究
- Orlando, FL27 項研究
- Las Vegas, NV23 項研究
- Miami, FL23 項研究
- Atlanta, GA20 項研究
- Dallas, TX20 項研究
- New York City, NY19 項研究
- Jacksonville, FL19 項研究
- Washington, DC19 項研究
- Austin, TX18 項研究
Fargo 的其他研究
- 非小細胞肺癌14 項研究
- 肺癌13 項研究
- 癌症（所有類型）10 項研究
- 肥胖症9 項研究
- 黑色素瘤9 項研究
- 前列腺癌8 項研究
- 大腸直腸癌7 項研究
- 乳癌7 項研究
- 頭頸部鱗狀細胞癌6 項研究
- 胰臟癌6 項研究
- 直腸癌6 項研究
- 結腸癌6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。